Biomarin Pharmaceutical (BMRN) EV to CFO (2010 - 2026)
Biomarin Pharmaceutical's (BMRN) EV to CFO stood at 11.90 in Q2 2026, unchanged from 11.90 a year earlier and up 19.7% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EV to CFO (2010 - 2026) Analysis & Trends
On a TTM basis, Biomarin Pharmaceutical's EV to CFO came in at 5.76 as of Jun 30, 2026, down 23.6% year-over-year; for FY2025, it was 11.92, down 40.1% from FY2024.
- Across earlier years, EV to CFO came in at 19.90 in FY2024 (-81.5%), 107.44 in FY2023 (+5.1%), 102.24 in FY2022 (+104.4%) and 50.03 in FY2021 (-71.3%).
- Quarterly EV to CFO has ranged from 9.77 in Q3 2025 to 119.79 in Q2 2022 over the past five years.
- Peak year-over-year performance for EV to CFO in the last five years was growth of 127.5% in Q2 2022, against a decline of 81.5% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 9.95 (Q1 2026), 11.92 (Q4 2025) and 9.77 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Biomarin Pharmaceutical | 10.95 Bn | 4.81 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.90 |
| Mar 31, 2026 | 9.95 |
| Dec 31, 2025 | 11.92 |
| Sep 30, 2025 | 9.77 |
| Jun 30, 2025 | 11.90 |
| Mar 31, 2025 | 17.54 |
| Dec 31, 2024 | 19.90 |
| Sep 30, 2024 | 30.05 |
| Jun 30, 2024 | 43.93 |
| Mar 31, 2024 | 55.43 |
| Dec 31, 2023 | 107.44 |
| Sep 30, 2023 | 112.14 |
| Jun 30, 2023 | 93.89 |
| Mar 31, 2023 | 115.94 |
| Dec 31, 2022 | 102.24 |
| Sep 30, 2022 | 80.30 |
| Jun 30, 2022 | 119.79 |
| Mar 31, 2022 | 90.66 |
| Dec 31, 2021 | 50.03 |
| Sep 30, 2021 | 46.82 |
API Access
Biomarin Pharmaceutical EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();